- Home
- DSU vs SRDX Comparison
DSU vs SRDX Comparison
Compare DSU & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSU
- SRDX
- Stock Information
- Founded
- DSU 1998
- SRDX 1979
- Country
- DSU United States
- SRDX United States
- Employees
- DSU N/A
- SRDX N/A
- Industry
- DSU Finance Companies
- SRDX Medical/Dental Instruments
- Sector
- DSU Finance
- SRDX Health Care
- Exchange
- DSU Nasdaq
- SRDX Nasdaq
- Market Cap
- DSU 510.1M
- SRDX 562.6M
- IPO Year
- DSU N/A
- SRDX 1998
- Fundamental
- Price
- DSU $10.81
- SRDX $39.75
- Analyst Decision
- DSU
- SRDX Hold
- Analyst Count
- DSU 0
- SRDX 4
- Target Price
- DSU N/A
- SRDX $43.00
- AVG Volume (30 Days)
- DSU 148.2K
- SRDX 177.1K
- Earning Date
- DSU 01-01-0001
- SRDX 01-30-2025
- Dividend Yield
- DSU 10.06%
- SRDX N/A
- EPS Growth
- DSU N/A
- SRDX N/A
- EPS
- DSU N/A
- SRDX N/A
- Revenue
- DSU N/A
- SRDX $126,078,000.00
- Revenue This Year
- DSU N/A
- SRDX $13.75
- Revenue Next Year
- DSU N/A
- SRDX $13.67
- P/E Ratio
- DSU N/A
- SRDX N/A
- Revenue Growth
- DSU N/A
- SRDX N/A
- 52 Week Low
- DSU $9.22
- SRDX $25.17
- 52 Week High
- DSU $11.40
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- DSU 35.72
- SRDX 55.78
- Support Level
- DSU $10.83
- SRDX $39.50
- Resistance Level
- DSU $10.90
- SRDX $40.39
- Average True Range (ATR)
- DSU 0.09
- SRDX 0.38
- MACD
- DSU -0.02
- SRDX -0.06
- Stochastic Oscillator
- DSU 4.41
- SRDX 46.67
About DSU Blackrock Debt Strategies Fund Inc.
Blackrock Debt Strategies Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide current income by investing in a diversified portfolio of U.S. companies' debt instruments including corporate loans. The fund's secondary investment objective is to provide capital appreciation.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.